| Amelia Anna Jarosz, PHARMD | |
|
17 Crystal Ave, Derry, NH 03038-2415 | |
| (603) 423-9330 | |
| Not Available |
| Full Name | Amelia Anna Jarosz |
|---|---|
| Gender | Female |
| Speciality | Pharmacist - Pharmacist Clinician (phc)/ Clinical Pharmacy Specialist |
| Location | 17 Crystal Ave, Derry, New Hampshire |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1134401979 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1835P0018X | Pharmacist - Pharmacist Clinician (phc)/ Clinical Pharmacy Specialist | RPH04396 (Rhode Island) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Amelia Anna Jarosz, PHARMD 615 Daniel Webster Hwy, Merrimack, NH 03054-2754 Ph: (603) 423-9330 | Amelia Anna Jarosz, PHARMD 17 Crystal Ave, Derry, NH 03038-2415 Ph: (603) 423-9330 |
News Archive
In recent years, faculty at the UCLA School of Dentistry have been expanding the traditional boundaries of dentistry through groundbreaking multidisciplinary research that has led to major advances in everything from stem cell science to saliva diagnostics. Now, a $5 million grant from the National Institutes of Health's National Institute of Dental and Craniofacial Research will allow the school to continue these pioneering efforts by creating a comprehensive research training program to help cultivate the next generation of dentist-scientists and oral health researchers.
The World Bank on Wednesday announced that its International Development Association (IDA) fund will receive $49.3 billion over the next three years, Bloomberg reports (Christie/Martens, 12/15).
Tart cherries could help athletes reduce muscle damage to recover faster from a tough workout, according to new research published in the American College of Sports Medicine's journal Medicine & Science in Sports & Exercise.
Administration officials announced Friday that consumers would be permitted to enroll in a health insurance plan on healthcare.gov as late as Dec. 23 for coverage that begins on Jan. 1 next year.
Calistoga Pharmaceuticals, Inc., the leader in the development of isoform-selective phosphatidylinositol 3 kinase (PI3K) inhibitors for the treatment of cancer and inflammatory diseases, today announced updated clinical data on CAL-101, the Company's oral, delta selective PI3K inhibitor, presented during two oral presentations at the 51st American Society of Hematology Annual Meeting in New Orleans.
› Verified 2 days ago
Joseph Doucette, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 48 E Broadway, Derry, NH 03038 Phone: 603-434-2600 | |
Frank Eugene Garland V, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 48 E Broadway, Derry, NH 03038 Phone: 603-434-2600 | |
Dr. Eric John Landry, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 48 East Broadway, Derry, NH 03038 Phone: 603-434-2600 | |
Ms. Karen L Coupe, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 20 Crystal Ave, Derry, NH 03038 Phone: 603-437-9799 Fax: 603-437-5642 | |
Valerie Tay, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 55 Crystal Ave, Derry, NH 03038 Phone: 603-437-9654 | |
Amina Gusic, PHARMD, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 20 Crystal Ave, Derry, NH 03038 Phone: 603-437-9799 |